Takeda’s zasocitinib landmark phase 3 plaque psoriasis data show promise to deliver clear skin in a once-daily pill, catalyzing a new era of treatment: Osaka, Japan Friday, Dece ...
Aviceda Therapeutics has released topline results from its phase 2b study, SIGLEC, evaluating AVD-104 in patients with ...
Guselkumab has received approval for moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy.1 ...
A preliminary analysis of recurrence rates by two methods to estimate the reduction in recurrence rate shows an approximately 80% reduction in recurrence rate in the fully enrolled, 250 patient ...
Aviceda Therapeutics ("the Company" or "Aviceda"), a clinical-stage biotechnology company developing innovative therapies for retinal diseases, today announced topline results from its SIGLEC Phase 2b ...
PM Modi’s travels have become a permanent feature of India’s political theatre. Yet, to dismiss them as spectacle alone would be to miss the deeper story unfolding beneath the surface.
Craig Morgan outlines why comparator clinical trials are useful and provides points to consider to ensure the best outcome. In clinical trials, a comparator drug (defined as ‘an investigational or ...
Despite randomised clinical trials (RCTs) being the gold standard for drug approval studies, the shift towards precision medicine has increased the use of single-arm trials (SATs). SATs lack results ...
Abstract: In this paper, a design for a low-noise, low-power, dual-tail dynamic latched comparator is introduced. The input referred noise is reduced through the use of a larger gain comparator ...
This guide is for the 128GB / 256GB version only, as they have NVMe SSDs. If you have a 64GB it is EMMC, and part of the motherboard, so you can't upgrade it. As per usual, the process described in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results